HTL Biotechnology
FranceWho owns HTL Biotechnology?
HTL Biotechnology is a French Biotech company, currently owned by Montagu Private Equity since 2021.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods · co-invest detected
Bridgepoint sold HTL Biotechnology to Montagu Private Equity in 2022 after 4 years.
More from Montagu VI
Other portfolio companies in the same fund.
US
Germany
LuxembourgMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns HTL Biotechnology?
HTL Biotechnology is currently owned by Montagu Private Equity, through Montagu VI, since 2021.
When did Montagu Private Equity acquire HTL Biotechnology?
Montagu Private Equity acquired HTL Biotechnology in 2021.
Who did HTL Biotechnology sell to?
Bridgepoint sold HTL Biotechnology to Montagu Private Equity in 2022 (Secondary).
Who has owned HTL Biotechnology over time?
HTL Biotechnology has been through 2 private-equity ownership periods: Bridgepoint · via Europe V (BE V) · 2018–2022 · sold to Montagu Private Equity · (Secondary); Montagu Private Equity · via Montagu VI · since 2021.